• Thurs news: Novartis buys Kate Therapeutics. Trump’s likely FDA pick. Bayer tries for new Nubeqa indications. New CSO for Amgen. Versant developing new type of obesity drug. See more on our front page

Michelle Weese

Switzerland country President being discontinued! This is a clear message that CH is no longer of importance. Michelle now has the legacy people reporting to her, for how long will they be around as this is clearly an attrition strategy.
Switzerland should be very concerned of the future residency of Novartis. It is clearly being positioned for a home country move.
 








Whats up with all the leadership picks now running the show? A speech writer over global strategy. All the BMS people with fairly low level experience and no tangible accomplishments taking top jobs and pushing down real players. The converted consultants who have no people leadership or tenure in any place to see results of their shiny powerpoints.
Feels like a Trump playbook for appointments. No experience required. Loyalty only job requirement
 








Around 80 comms, public affairs, patient engagement, media relations, digital, contractors will have gone by the year end. But she won’t stop there. No! Public affairs have to reapply for their jobs and next the countries will have to do the same. It will be into the hundreds gone. Not to mention the people who just couldn’t wait to be told they have a job or not who’ve gone elsewhere. This process is cruel in the extreme.
cruel. unprofessional. no integrity. empathy - out the window.
I bet she gets a big fat bonus - where's the values and behaviors now?
 




Novartis communications, public affairs and patient engagement will NEVER recover from this disastrous awful cruel process. These are highly educated professionals with deep knowledge of their subject matter. The reason why the Swiss press don't like Vas is because he doesn't speak the language and treats them like second class citizens. The Swiss journalists are hugely intelligent and thorough and he doesn't like them asking questions.
It wont matter when the HQ is moved to US. Disbanding the Swiss Country President and moving team into corp affairs shows the importance level of Switzerland now
 












Novartis communications, public affairs and patient engagement will NEVER recover from this disastrous awful cruel process. These are highly educated professionals with deep knowledge of their subject matter. The reason why the Swiss press don't like Vas is because he doesn't speak the language and treats them like second class citizens. The Swiss journalists are hugely intelligent and thorough and he doesn't like them asking questions.
Look at what's happening at BMS where the communications, corporate affairs, and patient engagement departments were in shambles when Michelle Weese left. They are slowly recovering because Michelle is gone and a new corporate affairs leader has taken over. A good department was ruined and its internal reputation was permanently damaged and may never recover.